Essex LLC trimmed its Deere & Company stake by 6.1% in the first quarter, offloading 756 shares to adjust its portfolio. This ...

Vertex Pharmaceuticals has presented compelling long-term data for its CRISPR/Cas9 gene-edited therapy, PrCASGEVY, targeting ...

LifePlan Financial LLC bought 760 shares of Lockheed Martin in the first quarter, adding about $340,000 worth of stock to its ...

Bristol-Myers Squibb announced promising progress on its Phase 2 Alzheimer’s clinical trial of BMS-986446, an experimental ...

Argus downgraded Regeneron Pharmaceuticals from a buy to a hold rating in its latest research report, signaling caution.

Washington Trust Advisors Inc. reduced its Starbucks holdings by 2% during the first quarter, selling 3,841 shares worth ...

Investors now have fresh options to consider with Automatic Data Processing’s August 22 expiration contracts. One notable put ...